These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2293210)

  • 1. Nebulization of liposomes. I. Effects of lipid composition.
    Niven RW; Schreier H
    Pharm Res; 1990 Nov; 7(11):1127-33. PubMed ID: 2293210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nebulization of liposomes. III. The effects of operating conditions and local environment.
    Niven RW; Carvajal TM; Schreier H
    Pharm Res; 1992 Apr; 9(4):515-20. PubMed ID: 1495897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
    Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
    Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebulization of liposomes. II. The effects of size and modeling of solute release profiles.
    Niven RW; Speer M; Schreier H
    Pharm Res; 1991 Feb; 8(2):217-21. PubMed ID: 2023870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vibrating-mesh nebulization of liposomes generated using an ethanol-based proliposome technology.
    Elhissi A; Gill H; Ahmed W; Taylor K
    J Liposome Res; 2011 Jun; 21(2):173-80. PubMed ID: 20684671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robustness of aerosol delivery of amikacin liposome inhalation suspension using the eFlow® Technology.
    Li Z; Perkins W; Cipolla D
    Eur J Pharm Biopharm; 2021 Sep; 166():10-18. PubMed ID: 34082122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: in vitro and in vivo evaluation.
    Zaru M; Sinico C; De Logu A; Caddeo C; Lai F; Manca ML; Fadda AM
    J Liposome Res; 2009; 19(1):68-76. PubMed ID: 19515009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary effects of chronic exposure to liposome aerosols in mice.
    Myers MA; Thomas DA; Straub L; Soucy DW; Niven RW; Kaltenbach M; Hood CI; Schreier H; Gonzalez-Rothi RJ
    Exp Lung Res; 1993; 19(1):1-19. PubMed ID: 8440200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the fluidity of liposome compositions on percutaneous absorption.
    Pérez-Cullell N; Coderch L; de la Maza A; Parra JL; Estelrich J
    Drug Deliv; 2000; 7(1):7-13. PubMed ID: 10895414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilization of aerosolized IFN-gamma by liposomes.
    Kanaoka E; Nagata S; Hirano K
    Int J Pharm; 1999 Oct; 188(2):165-72. PubMed ID: 10518672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of aging on the physical stability of liposome dispersions.
    Grit M; Crommelin DJ
    Chem Phys Lipids; 1992 Sep; 62(2):113-22. PubMed ID: 1423806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.
    Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA
    PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical properties of PEG-grafted liposomes.
    Sriwongsitanont S; Ueno M
    Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1238-44. PubMed ID: 12237543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrity of liposomes in presence of cyclodextrins: effect of liposome type and lipid composition.
    Hatzi P; Mourtas S; Klepetsanis PG; Antimisiaris SG
    Int J Pharm; 2007 Mar; 333(1-2):167-76. PubMed ID: 17101248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of cholesterol inclusion on the vesicular membranes of cationic lipids.
    Bhattacharya S; Haldar S
    Biochim Biophys Acta; 1996 Aug; 1283(1):21-30. PubMed ID: 8765090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
    Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
    J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermotropic phase behavior of hydrogenated soybean phosphatidylcholine-cholesterol binary liposome membrane.
    Kitayama H; Takechi Y; Tamai N; Matsuki H; Yomota C; Saito H
    Chem Pharm Bull (Tokyo); 2014; 62(1):58-63. PubMed ID: 24390493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular and serum stability of liposomal 2',3'-dideoxycytidine. Effect of lipid composition.
    Makabi-Panzu B; Gourde P; Désormeaux A; Bergeron MG
    Cell Mol Biol (Noisy-le-grand); 1998 Mar; 44(2):277-84. PubMed ID: 9593578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of anionic/nonionic surfactant mixtures with phosphatidylcholine liposomes.
    de la Maza A; Parra JL
    Arch Biochem Biophys; 1995 Sep; 322(1):167-73. PubMed ID: 7574671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of liposomes containing bio-enhancers and tetraether lipids in simulated gastro-intestinal fluids.
    Parmentier J; Becker MM; Heintz U; Fricker G
    Int J Pharm; 2011 Feb; 405(1-2):210-7. PubMed ID: 21145956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.